Please login to the form below

Not currently logged in
Email:
Password:

NeuroTherm appoints Gregory Cash as president and CEO

Joins pain management device manufacturers from HeartSine

Gregory Cash has been appointed president and CEO of US-based pain management device company NeuroTherm.

He joins from HeartSine Technologies, where he also served as president and CEO.

“This is a key appointment at an important time for NeuroTherm, and we are certain that Greg's leadership combined with his strategic vision  and experience make him the right person to lead the company through the next phase of rapid growth and development,” said Eric Bacon, chair of the board of directors at NeuroTherm.

Prior to his time at HeartSine, Cash served in numerous senior management roles of progressive responsibility in the US, Asia and Europe.

“While there are many challenges facing the medical device industry as a whole, NeuroTherm is poised for strong growth and will continue to make a positive difference in patients' lives,” said Cash.

24th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Brandcast Health

Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics